Stryker upgraded to outperform by Bear Stearns

Stryker Corp. was upgraded to outperform and a price target of $60 by Bear Stearns analyst Milton Hsu. The company's non-orthopedic business could continue to grow approximately 15% and the company could continue to reach its 20% earnings-per-share growth target. Bear Stearns believes Stryker is one of three large cap medtech stories under its coverage which could outperform in 2006 due to the company's ability to deliver consistently approximately 20% earnings-per-share growth. Shares of the Kalamazoo, Mich., medical products company were down 17 cents, or 0.34%, at $50.16 on volume of 2,941,000 shares versus the three-month running average of 1,902,230 shares. (NYSE: SYK)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.